Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4407216 | 0.87 | TP53 (0.43) | L3MBTL1ACHETP53TDP1SMN1; SMN2 | |
| SCHEMBL12810357 | 0.85 | LMNA (0.40) | L3MBTL1TDP1ALDH1A1MAPTTSHR | |
| SCHEMBL20798533 | 0.83 | TP53 (0.40) | L3MBTL1ACHETP53TDP1SMN1; SMN2 | |
| SCHEMBL12810428 | 0.82 | L3MBTL1 (0.49) | L3MBTL1SMN1; SMN2ALDH1A1NPC1RAB9A | |
| SCHEMBL470419 | 0.82 | ACHE (0.44) | L3MBTL1ACHETP53TDP1SMN1; SMN2 | |
| SCHEMBL6559494 | 0.81 | TSHR (0.46) | TP53SMN1; SMN2ALDH1A1CYP3A4KMT2A | |
| SCHEMBL17792449 | 0.80 | ACHE (0.43) | L3MBTL1ACHETP53TDP1SMN1; SMN2 | |
| SCHEMBL18812610 | 0.79 | L3MBTL1 (0.41) | L3MBTL1ACHETP53TDP1SMN1; SMN2 | |
| SCHEMBL8385833 | 0.78 | TP53 (0.43) | L3MBTL1ACHETP53TDP1SMN1; SMN2 | |
| SCHEMBL3872825 | 0.78 | TP53 (0.43) | L3MBTL1ACHETP53TDP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3318570-B1 | PHOSPHORIC ACID-P,P'-[5,5',6,6'-TETRAMETHYL-3,3'-BIS(1-METHYLETHYL)[1,1'-BIPHENYL]-2,2'-DIYL] P,P,P',P'-TETRAKIS(2,4-DIMETHYLPHENYL)-ESTER IN HYDROFORMYLATION | EVONIK DEGUSSA GMBH (DE) | 2019-08-07 | — | — | EP | claimed |
| EP-3318570-A1 | PHOSPHORIC ACID-P,P'-[5,5',6,6'-TETRAMETHYL-3,3'-BIS(1-METHYLETHYL)[1,1'-BIPHENYL]-2,2'-DIYL] P,P,P',P'-TETRAKIS(2,4-DIMETHYLPHENYL)-ESTER IN HYDROFORMYLATION | Evonik Degussa GmbH (DE) | 2018-05-09 | — | — | EP | claimed |
| CN-108059642-B | Phosphite ester and preparation method thereof | 赢创运营有限公司 | 2020-12-15 | — | — | CN | disclosed |
| CN-108070001-B | Bisphosphites having a 2, 4-tert-butylphenyl unit and their use as ligands in hydroformylation | 赢创运营有限公司 | 2020-10-13 | — | — | CN | disclosed |
| CN-108350010-B | Economical preparation of 2-propylheptanol | 赢创运营有限公司 | 2020-09-04 | — | — | CN | disclosed |
| EP-3374366-B1 | BIS-PHOSPHITES WITH 2,4-DIMETHYLPHENYL UNITS AND THEIR USE AS LIGANDS IN HYDROFORMYLATION | EVONIK OPERATIONS GMBH (DE) | 2019-12-18 | — | — | EP | disclosed |
| EP-3374366-B1 | BIS-PHOSPHITES WITH 2,4-DIMETHYLPHENYL UNITS AND THEIR USE AS LIGANDS IN HYDROFORMYLATION | EVONIK OPERATIONS GMBH (DE) | 2019-12-18 | — | — | EP | disclosed |
| EP-3318570-B1 | PHOSPHORIC ACID-P,P'-[5,5',6,6'-TETRAMETHYL-3,3'-BIS(1-METHYLETHYL)[1,1'-BIPHENYL]-2,2'-DIYL] P,P,P',P'-TETRAKIS(2,4-DIMETHYLPHENYL)-ESTER IN HYDROFORMYLATION | EVONIK DEGUSSA GMBH (DE) | 2019-08-07 | — | — | EP | disclosed |
| EP-3318569-B1 | BIS-PHOSPHITES WITH 2,4-TERT. BUTYLPHENYL UNITS AND THEIR USE AS LIGANDS IN THE HYDROFORMYLATION | EVONIK DEGUSSA GMBH (DE) | 2019-07-17 | — | — | EP | disclosed |
| EP-3318569-B1 | BIS-PHOSPHITES WITH 2,4-TERT. BUTYLPHENYL UNITS AND THEIR USE AS LIGANDS IN THE HYDROFORMYLATION | EVONIK DEGUSSA GMBH (DE) | 2019-07-17 | — | — | EP | disclosed |
| US-10227278-B2 | Economical production of 2-propylheptanol | EVONIK DEGUSSA GMBH (DE) | 2019-03-12 | — | — | US | disclosed |
| EP-2395010-A1 | Method for the purification of triorganophosphites by treatment with a basic additive | Invista Technologies S.A R.L. (CH) | 2011-12-14 | — | — | EP | disclosed |
| EP-1567468-B1 | A SELECTIVE SYNTHESIS OF ORGANOPHOSPHITES | INVISTA TECH SARL (CH) | 2011-03-16 | — | — | EP | disclosed |
| US-20100076212-A1 | METHOD FOR THE PURIFICATION OF TRIORGANOPHOSPHITES BY TREATMENT WITH A BASIC ADDITIVE | INVISTA NORTH AMERICA S.A R.L. (US) | 2010-03-25 | — | — | US | disclosed |
| US-20100076212-A1 | METHOD FOR THE PURIFICATION OF TRIORGANOPHOSPHITES BY TREATMENT WITH A BASIC ADDITIVE | INVISTA NORTH AMERICA S.A R.L. (US) | 2010-03-25 | — | — | US | disclosed |
| US-7629484-B2 | Method for the purification of triorganophosphites by treatment with a basic additive | INVISTA NORTH AMERICA S.A.R.L. (US) | 2009-12-08 | — | — | US | disclosed |
| US-7629484-B2 | Method for the purification of triorganophosphites by treatment with a basic additive | INVISTA NORTH AMERICA S.A.R.L. (US) | 2009-12-08 | — | — | US | disclosed |
| WO-2007109005-A2 | METHOD FOR THE PURIFICATION OF TRIORGANOPHOSPHITES BY TREATMENT WITH A BASIC ADDITIVE | INVISTA TECHNOLOGIES S.A R.L. (CH) | 2007-09-27 | — | — | WO | disclosed |
| US-20070219386-A1 | Method for the purification of triorganophosphites by treatment with a basic additive | INVISTA NORTH AMERICA S.A R.L. (US) | 2007-09-20 | — | — | US | disclosed |
| US-20070219386-A1 | Method for the purification of triorganophosphites by treatment with a basic additive | INVISTA NORTH AMERICA S.A R.L. (US) | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219386-A1 | Method for the purification of triorganophosphites by treatment with a basic additive | HRH3, PHOSPHO1, HRH4 | L3MBTL1 2925/4885ACHE 620/4885TP53 3729/4885 |
| US-20100076212-A1 | METHOD FOR THE PURIFICATION OF TRIORGANOPHOSPHITES BY TREATMENT WITH A BASIC ADDITIVE | HRH3, PHOSPHO1, HRH4 | L3MBTL1 2925/4885ACHE 620/4885TP53 3729/4885 |
| US-10227278-B2 | Economical production of 2-propylheptanol | ADH5, HRH4, HRH3 | L3MBTL1 1136/4885ACHE 1366/4885TP53 4826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.